Struth talk about bail, report wasnt bad, lots of ground to explore at boolaloo and we have cash to do it, cant even see any buy strength coming in.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%